Updated on 16 October 2026
HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Director at Interagens s.r.l.
Rome, Italy
About
We offer our expertise in AI, gamification and citizen science to (1) make sure that "Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for", (2) "validate novel [...] healthcare interventions", and (3) "Use and/or develop technologies, including digital ones (e.g. (generative) Artificial Intelligence, wearable technologies) to help implement and monitor the long-term efficacy of the intervention(s), as well as manage the disease and/or monitor their progression".
Topic
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Paola Rizzo
Director at Interagens s.r.l.
Rome, Italy
Project cooperation
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
jean-christophe cau
CEO at iki
Toulouse, France
Project cooperation
Study design and statistical analysis partner for clinical trials and intervention studies
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Rosa de Molina
CEO & CTO at Datharsis
Granada, Spain